Načítá se...
Leveraging natural killer cells for cancer immunotherapy
Natural killer (NK) cells are potent antitumor effector cells of the innate immune system. Based on their ability to eradicate tumors in vitro and in animal models, significant enthusiasm surrounds the prospect of leveraging human NK cells as vehicles for cancer immunotherapy. While interest in mani...
Uloženo v:
| Vydáno v: | Immunotherapy |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Future Medicine Ltd
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5941700/ https://ncbi.nlm.nih.gov/pubmed/28472904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2017-0013 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|